Hepatitis C is a viral disease that causes the functionality of the liver to decrease, leading to its inflammation. The disease affects around 4 million people each year in the United States alone. Approximately 75% of this population suffers from Hepatitis C Genotype 1. Chronic hepatitis C may lead to infection, cirrhosis, liver cancer, and eventual death. However, there is a variety of new treatment for hep c genotype 1 patients.
New Treatment for Hep C Genotype 1
Vosevi is a drug administered over a duration of 12 weeks. Do not use this drug if you are suffering from severe cirrhosis. Clinical trials yielded a success rate of 96-97%. This drug can be used to effectively treat patients suffering from hep C genotype 1. Consult a doctor before taking any form of medication as the treatment recommendation for Vosevi varies. Your doctor will decide depending on your prior treatment history and the specific genotype. Some of the common side effects experienced are nausea, diarrhea, headaches, and fatigue.
Pak is a drug that had a success rate of 97% while curing people with hepatitis C genotype 1 during clinical trials. Pak is an oral drug. It is free of any and its related side effects. Do not use this drug if you are suffering from severe cirrhosis.
XR is an advanced form of the drug. It combines all the initial ingredients of Pak along with additional ingredients that provide a more effective and convenient dosage. This drug is especially recommended as a new treatment for hep C genotype 1.
EPCLUSA is approved for the treatment of adults with chronic hepatitis C ranging from the genotypes 1-6. It usually takes around 12 weeks for a patient to be cured of the disease. The initial trial testing yielded a 98% success rate. Using ribavirin in combination with EPCLUSA yields the best possible result. Approved in 2016, the most common side effects of EPCLUSA are headaches and fatigue. When EPCLUSA is given with ribavirin, the common side effects include fatigue, headaches, anemia, nausea, insomnia, and diarrhea. It is a very popular drug in today’s market and is highly recommended.
Featured Image: Depositphotos/© tashatuvangoPosted on May 5, 2023